Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.
Earlier this year, a team of Yale researchers showed that the concentration of COVID-19 RNA in sewage mirrors the spread of the disease through a population. In a new study, they find that testing sewage can serve as an early indicator of an outbreak relative to hospitalizations.
Efforts in the late 1960s to desegregate hospitals in the American South did not significantly contribute to improvements in the Black infant mortality rate, finds a new study co-authored by Dean Kerwin Charles.
Epidemiological models have played an influential role in governments’ responses to the COVID-19 pandemic. Yale SOM’s Edieal Pinker takes a look back at one of the most influential models and argues that such rigorous efforts at understanding the likely course of the disease, while imperfect, are critical to good decision making.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Yale SOM’s Jason Abaluck and his co-authors calculated that the Medicare Advantage plans appreciably influence the survival rates of their enrollees. Shutting down the plans with the highest mortality rates could save thousands of lives per year.